Filing Details

Accession Number:
0001579587-23-000005
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-25 16:17:55
Reporting Period:
2023-08-23
Accepted Time:
2023-08-25 16:17:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1023024 Ani Pharmaceuticals Inc ANIP Pharmaceutical Preparations (2834) 582301143
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1579587 G. James Marken C/O Ani Pharmaceuticals, Inc.
210 Main Street West
Baudette MN 56623
Svp Ops & Prod Dev No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-08-23 3,750 $40.59 135,377 No 4 M Direct
Common Stock Acquisiton 2023-08-23 1,667 $33.00 137,044 No 4 M Direct
Common Stock Disposition 2023-08-23 3,932 $63.00 133,112 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2023-08-23 3,750 $40.59 3,750 $40.59
Common Stock Stock Option (right to buy) Disposition 2023-08-23 1,667 $33.00 1,667 $33.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2026-04-06 No 4 M Direct
0 2024-03-31 No 4 M Direct
Footnotes
  1. 25% of the total options vested on each of April 7, 2017, April 7, 2018, April 7, 2019, and April 7, 2020.
  2. 25% of the total options vested on each of April 1, 2015, April 1, 2016, April 1, 2017, and April 1, 2018.